Abstract
Whole-body hyperthermia (WBH) is a modality that was developed to treat disseminated cancer (LARKIN et al. 1977; Pettigrew et al. 1974a, b). It is generally used in combination with chemotherapy (Bull et al. 1987, 1992b; Engelhardt et al. 1982, 1990; Koga et al. 1985; Page et al. 1992a; Robins et al. 1993), and less frequently with radiation; although therapies combining WBH with cytokines also promise to become effective anticancer treatments (Anjum and Fleischmann 1992; Doleire et al. 1992; Geehan et al. 1993; Makino et al. 1993a; Robins et al. 1989; Tapazaglou et al. 1990).In Addition to its major application to treat metastic disease, WBH may be useful with chemotherapy as a neoadjuvant or adjuvant treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams DB (1993) Systemic responses to challenge infection with Haemonchus contortus in immune Merino sheep.,Vet Res Commun 17: 25 – 35
Adwankar MK, Chitnis MP (1984) Effect of hyperthermia alone and in combination with anticancer drugs on the viability of P388 leukemic cells., Tumori 70: 231 – 234
Alberts DS, Peng YM, Chen HSG, Moon TE, Cetas TC, Hoschele JD (1980) Therapeutic synergism of hyperthermia/cis-platinum in a mouse tumor model. J Natl Cancer Inst 65: 455 – 461
Alonso K, Pontiggia P, Nardi C, Sabato A, Cuppone-Curto F (1992) Systemic hyperthermia in the treatment of HIV-related Kaposi’s sarcoma. A phase I study. Biomed Pharmacother 46: 21 – 24
Anjum A, Fleischmann WRJ (1992) Effect of hyperthermia on the antitumor actions of interferons. J Biol Regul Homeost Agents 6: 75 – 86
Armour EP, Wang ZH, Corry P, Martinez A (1991) Sensitization of rat 91 gliosarcoma cells to low dose rate irradiation by long duration 41°C hyperthermia. Cancer Res 51: 3088 – 3095
Armour EP, McEachern D, Wang Z, Corry PM, Martinez A (1993) Sensitivity of human cells to mild hyperthermia. Cancer Res 53: 2740 – 2744
Baba H, Siddik ZH, Strebel FR, Jenkins GN, Bull JMC (1989) Increased therapeutic gain of combined cis-diamminedichloro-platinum (II) and whole body hyperthermia by optimal heat scheduling in the rat. Cancer Res 49: 7041 – 7044
Baba H, Stephens LC, Strebel FR, Siddik ZH, Newman RA, Ohno S, Bull JMC (1991) Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia. Cancer Res 51: 3559 – 3567
Baba H, Siddik ZH, Strebel FR, Jenkins GN, Bull JMC (1989) Increased therapeutic gain of combined cis-diamminedichloro-platinum (II) and whole body hyperthermia by optimal heat scheduling in the rat. Cancer Res 49: 7041 – 7044
Barlogie B, Corry PM, Yip E, et al. (1979) Total-body hyperthermia with and without chemotherapy for advanced human neoplasms., Cancer Res 39: 1481 – 1489
Barlogie B, Corry P, Drewinko B (1980) In vitro thermo-chemotherapy of human colon cancer cells with cis- dichlorodiammineplatinum (II) and mitomycin C. Cancer Res 40: 1165 – 1170
Bates DA, Mackillop WJ (1986) Hyperthermia, adriamycin transport, and cytotoxicity in drug-sensitive and-resistant Chinese hamster ovary cells. Cancer Res 46: 5447 – 5481
Ben-Hur E, Elkind M (1974) Thermal sensitization of Chinese hamster cells to methyl methanesulfonate: relation of DNA damage and repair to survival response. Cancer Biochem Biophys 1: 23 – 32
Block J, Harris P, Peale A (1975) Preliminary observations on temperature-enhanced drug uptake by leukemic leukocytes in vitro. Cancer Chemother Rep 59: 985 – 988
Braun J, Hahn GM (1975) Enhanced killing by bleomycin and 43°C hyperthermia and the inhibition of recovery from potentially lethal damage. Cancer Res 35: 2921 – 2927
Brett D, Schloerb P (1962) Intermittent hyperthermia on Walker 256 carcinoma. Arch Surg 85: 154 – 157
Bronk B, Wilkins R, Regan JD (1973) Thermal enhancement of DNA damage by an alkylating agent in human cells., Biochem Biophys Res Commun 52: 1064 – 1070
Bruns P (1888) Die Heilwirkung des Erysipels auf Geschwulste., In: Bruns P (ed) Beitrage zur klinischen Chirurgie, Mitteilungen aus der chirurgischen Klinik zu Tubingen. Verlag der H. Laupp’schen Buchhandlung, Tubingen, pp 28 – 30
Bull JMC (1983) Systemic hyperthermia: background and principles. In: Storm FK (ed) Hyperthermia in cancer therapy. GK Hall, Boston, Mass, pp 401 – 407
Bull JMC (1994) A review of systemic hyperthermia. A new therapy in the treatment of cancer., In: Vaeth JM (ed) Frontiers in radiation therapy and oncology. Karger, Basel, pp 171 – 177
Bull JMC, Lees DE, Schuette J, et al. (1978) Whole body hyperthermia - now a feasible addition to cancer treatment. Proc Am Soc Clin Oncol 14: 405
Bull JMC, Lees DE, Schuette WH, et al. (1979) Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. Ann Intern Med 90: 317 – 323
Bull JMC, Lees DE, Schuette W, Smith R, Glatstein E, DeVita V Jr (1982) Immunological and physiological responses to whole body hyperthermia. Monogr Natl Cancer Inst 61: 77 - 79
Bull JMC, Mansfield B, Cronau L (1987) Whole body hyperthermia with chemotherapy in the treatment of metastatic colon carcinoma., The 8th International Congress of Radiation Research 1: 328
Bull JMC, Strebel FR, Sunderland BA, Bulger RE, Edwards M, Siddik ZH, Newman RA (1988)0-[-hydroxyethyl)-rutoside]-mediated protection of renal injury associated with cisdiamminedichloroplatinum (II)/hyperthermia treatment. Cancer Res 48: 2239–2244
Bull JMC, Cronau L, Newman B, et al. (1992a) Chemotherapy resistant sarcoma treated with whole body hyperthermia (WBH) combined with 1-3 bis(2-chloroethyl)-l- nitrosourea (BCNU). Int J Hyperthermia 8: 297 – 305
Bull JMC, Cronau L, Bigham C, Weiss G, Tonnesen A (1992b) A phase II study of whole body hyperthermia (WBH) with mitomycin C (mito-C) and continuous intravenous (civ) 5-fluorouracil (5-FU) in colon cancer. Proceedings of the 83rd annual meeting of the American Association of Cancer Research 33: 1500
Busch W (1866) Uber den Einfluss welche heftigere Erysi- pelen zuweilig auf organisierte Neubildungenausuben. Verhandlungen Naturhist Preuss Rhein Westphal, Bonn 23: 28 – 30
Chitnis M, Adwankar M (1986) Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia. Tumori 72: 469 – 473
Chitnis M, Juvekar A, Adwankar M, Advani S (1986) Inhibition of DNA synthesis by lonidamine and hyperthermia in human chronic myeloid leukemia cells. Anticancer Res 6: 749 – 752
Cohen JD, Robins HI (1987) Hyperthermic enhancement of cis-diammine-l,l-cyclobutane dicarboxylate platinum (II) cytotoxicity in human leukemia cells in vitro. Cancer Res 47: 4335 – 4337
Cohen JD, Robins HI (1990) Thermal enhancement of tetraplatin and carboplatin in human leukemic cells in vitro. Int J Hyperthermia 6: 1013 – 1017
Cohen JD, Robins HI, Schmitt C (1989) Interactions of hyperthermia with carboplatin, cisplatin and etopside in human leukemia cells in vitro. Cancer Lett 44: 205 – 210
Coley WC (1893) The treatment of malignant tumors by repeated inoculations of erysipelis: with a report of ten original cases. Am J Med Sci 105: 487 – 511
Croghan M, Shimm D, Dean S, Booth A, Modaino M, Meyskins F, Gerner E (1990) Treatment of disseminated malignant melanoma with alpha-difluoromethylornithine (DFMO) and systemic hyperthermia (S delta). Proc Annu Meet Am Assoc Cancer Res 31: A1171
Cronau L, Bourke D, Bull JMC (1984) General anesthesia for whole body hyperthermia. Cancer Res 44: 4873s–4877s
Dahl O (1982) Interaction of hyperthermia and doxorubicin on a malignant neurogenic rat cell line (BT4C) in culture., Monogr Natl Cancer Inst 61: 251 – 253
Dahl O (1983) Hyperthermic potentiation of doxorubicin and 4;-epi-doxorubicin in a transplantable neurogenic rat tumor (B1T4A) in BD IX rats. Int J Radiat Oncol Biol Phys 9: 203 – 207
Dahl O, Mella O (1982) Enhanced effect of combined hyperthermia and chemotherapy (bleomycin, BCNU) in a neurogenic rat tumour (BT4A) in vivo., Anticancer Res 2: 359 – 364
Dewhirst MW, Sim DA (1984) Analysis of prognostic variables which influence early and long-term response of pet animal tumors to radiation alone and radiation plus heat., Front Radiat Ther Oncol 18: 1951 – 1961
Dewhirst M, Sim D, Sapareto S, Conner W (1984) The importance of minimum tumor temperature in determining early and long term responses of spontaneous canine and feline tumors to heat and radiation. Cancer Res 44: 43 – 50
dOleire F, Spriggs D, Bird A, Schmitt CL, Robins HI (1992) The interaction of alpha-tumor necrosis factor, melphalan and 41.8°C hyperthermia in L929 cells. Proc Annu Meet Am Assoc Cancer Res 34: A2163
dOleire F, Schmitt CL, Robins HI, Cohen JD, Spriggs D (1993) Cytokine induction in humans by 41.8 degrees C whole-body hyperthermia. Letter J Natl Cancer Inst 85: 833 – 834
Donaldson S, Gordon L, Hahn GM (1978) Protective effect of hyperthermia against the cytotoxicity of acti-nomycin D on Chinese hamster cells,. Cancer Res Treat Rep 62: 1489 – 1495
Engelhardt R, Neumann H, von der Tann M, Lohr G (1982) Preliminary results in the treatment of oat cell carcinoma of the lung by combined application of chemotherapy (CT) and whole-body hyperthermia. In: Gautherie JM, Albert E (eds) Biomedical thermology, progress in clinical biological research. Liss, New York, pp 761 – 775
Engelhardt R, Muller U, Weth-Simon R, Neumann HA, Lohr GW (1990) Treatment of disseminated malignant melanoma with cisplatin in combination with whole-body hyperthermia and doxorubicin. Int J Hyperthermia 6: 511 – 515
Engin K, Tupchong L, Waterman F, Nerlinger R, Hoh L, McFarlane J, Leeper D (1993a) Thermoradiotherapy with combined interstitial and external hyperthermia in advanced tumours in the head and neck with depth > or = 3 cm. Int J Hyperthermia 9: 645 – 654
Engin K, Tupchong L, Waterman F, Komarnicky L, Mansfield C, Leeper D (1993b) “Patchwork” fields in thermoradiotherapy for extensive chest wall recurrences of breast carcinoma. Breast Cancer Res Treat 27: 263–270
Engin K, Leeper D, Thistlethwaite A, Tupchong L, McFarlane J (1994a) Tumor extracellular pH as a prognostic factor in thermoradiotherapy. Int J Radiat Oncol Biol Phys 29: 125 – 132
Engin K, Tupchong L, Waterman F, et al. (1994b) Thermo-radiotherapy for superficial tumour deposits in the head and neck,. Int J Hyperthermia 10: 153 – 164
Epelbaum R, Teicher B, Holden S, Ara G, Varsheny A, Herman T (1992) Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo. Eur J Cancer 28A: 794 – 800
Fajardo LF, Schreiber AB, Kelly NI, Hahn GM (1985) Thermal sensitivity of endothelial cells. Radiat Res 103: 276 – 285
Fisher GA, Hahn GM (1982) Enhancement of cis-diam- minedichloroplatinum (cis-DDP) cytotoxicity by hyper-thermia,. Monogr Natl Cancer Inst 61: 255
Geehan DM, Fabian DF, Lefor AT (1993) Immunotherapy and whole-body hyperthermia as combined modality treatment of a subcutaneous murine sarcoma,. J Surg Oncol 53: 180 – 183
Gerard H, Egorin MJ, Whitacre M, van Echo DA, Aisner J (1983) Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum (I) and whole-body hyperthermia. Cancer Chemother Pharmacol 11: 162 – 166
Gerard H, van Echo DA, Whitacre M, et al. (1984) Doxorubicin, cyclophosphamide, and whole body hyper-thermia for treatment of advanced soft tissue sarcoma,. Cancer 53: 2585 – 2591
Ghussen F. Kruger I, Groth W, Stutzer H (1988) The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma. Cancer 61: 654 – 659
Giovanella B, Lohman W, Heidelberger C (1970) Effects of elevated temperatures and drugs on the viability of LI 210 leukemia cells. Cancer Res 30: 1623 – 1631
Goss P, Parsons P (1977) The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines. Cancer Res 37: 152 – 156
Hahn GM (1978) Interactions of drugs and hyperthermia in vitro and in vivo,. In: Streffer C (ed) Proceedings of the international symposium on hyperthermia in cancer treatment. Urban and Schwarzenberg, Baltimore, pp 72 – 79
Hahn GM (1982) Hyperthermia and cancer,. Plenum Press, New York
Hahn GM, Shiu E (1983) Effect of pH and elevated temperature on the cytotoxicity of some chemothera-peutic agents in Chinese hamster cells in vitro,. Cancer Res 43: 5789 – 5781
Hahn GM, Strande D (1976) Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J Natl Cancer Inst 57: 1063 – 1067
Hall J, Bull JMC, Cronau L (1988) Hypo- and hyperthermia in clinical auditory brain stem response measurement: two case reports. Ear Hear 4: 137 – 143
Har-Kedar I (1975) Effect of hyperthermia and chemotherapy in EMT6 cells,. Proceedings of the international symposium on cancer therapy by hyperthermia and radiation,. pp 91 – 93
Hazan G, Ben-Hur E, Yerushalmi A (1981) Synergism between hyperthermia and cyclophosphamide in vivo: the effect of dose fractionization. Eur J Cancer 6: 681 – 684
Herman TS (1983) Temperature dependence of adriamycin, cis-diamminedichloroplatinum (II), bleomycin, and 1,3- bis(2-chloroethyl)-l-nitrosourea cytoxocicity in vitro. Cancer Res 43: 365 – 369
Herman TS, Cress A, Sweets C, Gerner E (1981) Reversal of resistance to methotrexate by hyperthermia in Chinese hamster ovary cells. Cancer Res 41: 3840 – 3843
Herman TS, Zukoski CA, Anderson RM, et al. (1982) Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies. Cancer Treat Rep 66: 259 – 265
Herman TS, Henle K, Nagle W, Moss A, Monson T (1984) Effect of step-down heating on the cytotoxicity of adriamycin, bleomycin, and cis-diamminedichloroplatinum (II). Cancer Res 44: 1823 – 1826
Herman TS, Teicher BA, Collins LS (1988) Effect of hypoxia and pH on the cytotoxicity of fotir platinum complexes at normal and hyperthermic temperatures,. Cancer Res 48: 2342 – 2347
Herman TS, Teicher BA, Pfeffer M, Khandekar V (1990) Interaction with hyperthermia of platinum complexes of triaminotriphenylmethane dyes. Int J Hyperthermia 6: 629 – 639
Herman TS, Teicher B A, Varsheny A, Khandekar V, Brann T (1992) Effect of hypoxia and acidosis on the cytotoxicity of mitoxantrone, bisantrene and amsacrine and their platinum complexes at normal and hyperthermic temperatures. Anticancer Res 12: 827 – 836
Hinkelbein W, Birmelin M, Menger D, Engelhardt R (1988) Toxic effects of irradiation or doxorubicin in combination with moderate whole-body hyperthermia on bone marrow in rats. Recent Results Cancer Res 109: 71 – 82
Honess D, Bleehen N (1982) Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain. Br J Cancer 46: 236 – 248
Honess D, Bleehen N (1985a) Potentiation of melphalan by systemic hyperthermia in mice: therapeutic gain for mouse lung microtumours. Int J Hyperthermia 1: 57 – 68
Honess D, Bleehen N (1985b) Thermochemotherapy with cisplatinum, CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: therapeutic gain for melphalan only. Br J Radiol 58: 63 – 72
Johnson H, Pavelec M (1973) Thermal enhancement of thio-TEPA cytotoxicity. J Natl Cancer Inst 50: 903-908 J
oiner M, Steel G, Stephens I (1982) Response of two mouse tumours to hyperthermia with CCNU or melphalan. Br J Cancer 45: 17 – 26
Joshi D, Barendsen G (1984) Hyperthermic modification of drug effectiveness for reproductive death of cultured mamalian cells. Indian J Exp Biol 22: 248 – 250
Kano E, Furukawa-Furuya M, Nitta K, et al. (1988) Sensitivities of bleomycin-resistant variant cells enhanced by 40°C hyperthermia in vitro. Int J Hyperthermia 4: 547 – 553
Kapp D (1988) Hyperthermia treatment (HT) of superficial malignancies. Sugatrara T, Saito M (eds) The 5th international symposium of hyperthermic oncology
Kido Y, Kuwano H, Maehara Y, Mori M, Matsuoka H, Sugimachi K (1991) Increased cytotoxicity of low-dose, long-duration exposure to 5-fluorouracil of V-79 cells with hyperthermia. Cancer Chemother Pharmacol 28: 251 – 254
Kilbourne R, Gross S, Jubran A, Adams J, Griffith O, Levi R, Lodato R (1990) NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87: 3629 – 3632
Kim JH, Kim SH, Alfieri A, Young CS, Silvestrini B (1984) Lonidamine: a hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo. Oncology 4: 30 – 35
Kim YD, Lake R, Lees DE, Schuette WH, Bull JMC, Weise V, Kopin IJ (1979a) Hemodynamic and plasma chatecholamine responses to hyperthermia cancer therapy in humans. Am J Physiol 237: H570
Kim YD, Lees DE, Lake CR, Whang-Peng J, Schuette W, Smith R, Bull JMC (1979b) Hyperthermia potentiates doxorubicin-related cardiotoxic effects. JAMA 24: 1816 – 1817
Klaubert W, Eisler K, Lange J, Wilmanns W (1988) Coagulation and fibrinogenolysis during whole-body hyperthermia. Recent Results Cancer Res 107: 205 – 208
Klostergaard J, Lu S, Tomasovic S (1991) Potentiation of TNF cytotoxicity by hyperthermia: comparative in vitro studies of TNF-a, TNF-?’, andTNF-S AM2. Lymphokine Res
Koga S, Maeta M, Shimizu N, et al. (1985) Clinical effects of total-body hyperthermia combined with anticancer chemotherapy for far-advanced gastrointestinal cancer. Cancer 55: 1641 – 1647
Kusumoto T, Teicher B (1994) Analysis of the interaction of seven platinum complexes with murine FSall fibrosarcoma in culture. 18th international congress of chemotherapy,. Proc Annu Meet Am Assoc Cancer Res 35: A3803
Larkin JM, Edwards WS, Smith DE, Clark PJ (1977) Systemic thermotherapy: description of a method and physiologic tolerance in clinical subjects,. Cancer 40: 3155 – 3159
Lees DE, Kim YD, Bull JMC, Whang-Peng J, Smith R, MacNamara TG (1980) Anesthetic management of whole body hyperthermia with and without chemotherapy. Anesthesiology 52: 418 – 428
Lees DE, Kim YD, Dubois M, Bull JMC, Smith R, Schuette WH, MacNamara TG (1982) Internal organ hypoxia during hyperthermia cancer therapy in humans. In: Dethlefsen L, Dewey WC (eds) Proceedings of the third international symposium on cancer therapy by hyperthermia, drugs and radiation. National Cancer Institute Monograph, Fort Collins, CO, pp 339 – 401
Levin W, Blair R (1978) Clinical experience with combined whole-body hyperthermia and radiation. In: Streffer C, van Beuningen D, Dietzel F (eds) Cancer therapy by hyperthermia and radiation. Urban and Schwarzenberg, Baltimore, pp 322 – 325
Li D, Hahn G (1984) Response of RIF tumors to heat and drugs: dependence on tumor size. Cancer Treat Rep 68: 1149 – 1151
Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ (1992) High dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10: 52 - 60
Loshek DD, Greenlaw RH, Doyle LA (1981) Whole body hyperthermia using a water circulator,. Strahlentheroncol 157: 620 – 621
Makino M, Sakaguchi Y, Strebel FR, Jenkins G, Ohno S, Klostergaard J, Tomasovic S, Bull JMC, et al. (1993a) The importance of timing and sequence in using tumor necrosis factor (TNF) in a combination treatment with whole body hyperthermia (WBH) + carboplatin (CBDCA) in rats. Proceedings of the 84th meeting of the American Association for Cancer Research 34: 388 (2311)
Makino M, Stephens LC, Sakaguchi Y, Lodato RF, Strebel FR, Jenkins G, Bull JMC (1993b) Alteration in blood profile and tissue histopathology caused by tumor necrosis factor combined with whole body hyperthermia in rats,. Proceedings of the 41st annual meeting of the Radiation Research society and the 13th annual meeting of the North American Hyperthermia Society,. 29: 50
Marmor JB (1979) Interactions of hyperthermia and chemotherapy in animals,. Cancer Res 39: 2269 – 2276
Marmor JB, Kozak D, Hahn G (1979) Effects of systemically administered bleomycin or adriamycin with local hyperthermia on primary tumor and lung metastases. Cancer Treat Rep 63: 1279 – 1290
Martinez A, Gersten D, Leslie J, Borrego C, Armour E, Corry P (1993) Interstitial thermobrachy therapy with continuous mild hyperthermia for the treatment of locally advanced or recurring pelvic malignancies. 41st annual meeting of the Radiation Research Society 41: 122 (S-12-4)
McChesney Gillette S, Dawson C, Scott R, et al. (1993) Whole-body hyperthermia combined with hyperfrac- tionated irradiation of the thorax in dog: acute physiological response. Int J Hyperthermia 9: 369 – 382
Mella O (1985) Combined hyperthermia and cis- diamminedichloroplatinum in BD IX rats with transplanted BT4A tumours. Int J Hyperthermia 1: 171 – 183
Mella O, Eriksen R, Dahl O, Laerum O (1987) Acute systemic toxicity of combined cis-diamminedichlorpla- tinum and hyperthermia in the rat. Eur J Cancer 23: 365 – 373
Meyn R, Corry P, Fletcher S. Demetriades M (1979) Thermal enhancement of DNA strand breakage in mammalian cells treated with bleomycin. Int J Radiat Oncol Biol Phys 5: 1487 – 1489
Meyn R, Corry P, Fletcher S, Demetriades M (1980) Thermal enhancement of DNA damage in mammalian cells treated with cisdiamminedichloroplatinum (II). Cancer Res 47: 4335 - 4337
Mivechi N, Li G (1988) Heat sensitivity, thermotolerance and profile of protein synthesis of human bone marrow progenitors. Cancer Res 48: 3630 – 3633
Mizuno S, Amagai M, Ishida A (1980) Synergistic cell killing by antitumor agents and hyperthermia in cultured cells. Jpn J Cancer Res 71: 471 – 478
Morgan J, Bleehen N (1980) A comparison of the interaction between hyperthermia and bleomycin on the EMT6 tumour as a monolayer or spheroids in vitro and in vivo,. In: Arcangeli G, Mauro F (eds) Hyperthermia in radiation oncology. Masson, Milan, pp 165 – 170
Muckle D, Dickson J (1973) Hyperthermia (42°C) as an adjuvant to radiotherapy and chemotherapy in the treatment of the allogeneic VX2 carcinoma in the rabbit. Br J Cancer 27: 307 – 315
Mulcahy R, Gipp J, Tanner M (1987) Enhancement of misonidazole chemopotentiation by mild hyperthermia (41°C) in vitro and selective enhancement in vivo. Int J Radiat Biol 52: 57 – 65
Mulcahy R, Gipp J, Tanner M (1988) Sensitization of nitrosourea-resistant Mer+ human tumor cells to N’-(2- chloroethyl)-N-cyclohexyl-/V-nitrosoruea by mild (41°C) hyperthermia. Cancer Res 48: 1086 – 1090
Muzuno S, Amagai M, Ishida A (1980) Synergistic cell killing by antitumor agents and hyperthermia in cultured cells. Jpn J Cancer Res 34: 397 – 406
Nauts HC (1975) Pyrogen therapy of cancer: a historical overview and current activities,. Proc 1st international symposium on cancer therapy by hyperthermia and radiation,. Wizenberg M, Robinson JE (eds) Proc of the International Symposium on Cancer There by Hyperthermia and Radiation. American College of Radiology Press, Baltrmore, MD 239 – 250
Nauts HC (1982) Bacterial pyrogens: beneficial effects on capycer patients. In: Gutherie JM, Albert E (eds) Biomedical thermology, progress in clinical biological research. Liss, New York, pp 687 – 696
Nauts HC, Fowler GA, Bogatko FH (1953) A review of the influence of bacterial infections and bacterial pro-ducts (Coley’s toxins) on malignant tumors in men. Acta Med Scand (suppl) 276: 1 – 103
Neta R, Oppenheim J (1991) Radioprotection with cytokines - learning from nature to cope with radiation damage. Cancer Cells 3: 391 – 396
Neta R, Perlstein R, Vogel S, Ledney G, Abrams J (1992) Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J Exp Med 175: 689 – 694
Neumann H, Fiebig H, Lohr G, Engelhardt R (1985) Effects of cytostatic drugs and 40.5°C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice. J Natl Cancer Inst 75: 1059 – 1066
Neville A, Sauder D (1988) Whole body hyperthermia (41-42°C) induces interleukin-1 in vivo. Lymphokine Res 7 201 – 204
Novotney C, Page R, Macy D, et al. (1992) Phase I evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma. J Vet Intern Med 6: 245 – 249
O’Hara M, Lin C, Leeper D (1991a) The thermal response and development of thermotolerance of the bone marrow stromal progenitor CFU-E. Exp Hematol 99: 1096 – 1100
O’Hara M, Pollard M, Xiong Q, Leeper D (1991b) The development of thermotolerance in bone marrow CFU- S during chronic hyperthermia. Exp Hematol 99: 878 – 881
Ohno S, Strebel FR, Siddik ZH, Stephens LC, Khokar A, Bull JMC (1991) The effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats. Cancer Res 51: 2994 - 3000
Ohno S, Strebel FR, Stephens LC, Siddik ZH, Makino M, Khokar AR, Bull JMC (1993) Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats. Br J Cancer 68: 469 – 474
Ohno S, Strebel FR, Stephens LC, Siddik ZH, Makino M, Bull JMC (1991) Effect of bleomycin or liblomycin Combined with whole body hyperthermia in tumor and normal tissue in rats. Droc 9th Internat Congress of Radiation Research, Toronto, Canada
Oleson JR, Dewhirst MW, Harrelson JM, Leopold KA, Samulski TV, Tso CY (1989) Tumor temperature distributions predict hyperthermia effect. Int J Radiat Oncol Biol Phys 16: 559 – 570
Oleson JR, Samulski TV, Leopold KA, Clegg ST, Dewhirst MW, Dodge RK, George SL (1993) Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 25: 289 – 297
Oshnoshi T, OhnumaT, Beranek J, Holland J (1985) Combined cytotoxicity effect of hyperthermia and anthra-cycline antibiotics on human tumor cells. J Natl Cancer Inst 74: 275 – 281
Osieka R, Magin RL, Atkinson ER (1978) The effect of hyperthermia on human colon cancer xenografts in nude mice. In: Streffer C (ed) Cancer therapy by hyperthermia and radiation. Urban and Schwarzenberg, Munich, pp 287 – 290
Page RL, Meyer RE, Thrall DE, Dewhirst MW (1987) Cardiovascular and metabolic response of tumour- bearing dogs to whole body hyperthermia,. Int J Hyperthermia 3: 513 – 525
Page RL, Thrall DE, Dewhirst MW, et al. (1991) Phase I study of melphalan and whole body hyperthermia in dogs with malignant melanoma. Int J Hyperthermia 7: 559 – 566
Page RL, Macy DW, Ogilvie GK, et al. (1992a) Phase III evaluation of doxorubicin and whole body hyperthermia in dogs with lymphoma,. Int J Hyperthermia 8: 187 – 197
Page RL, Thrall DE, George SL, et al. (1992b) Quantitaive estimation of the thermal dose-modffying factor for cis-dimminedichloroplatinum (CDDP) in tumour-bearing dogs,. Int J Hyperthermia 8: 761 – 769
Parks LC, Minaberry D, Smith DP, Neely WH (1979) Treatment of far advanced bronchogenic carcinoma by extracorporeally induced systemic hyperthermia. J Thorac Cardiovasc Surg 28: 883 – 897
Parks LC, Smith GV (1983) Systemic hyperthermia by extracorporeal induction: techniques and results. In:Storm FK (ed) Hyperthermia in cancer therapy. C.K. Hall, Boston, Mass, pp 407 – 447
Perry DJ, Weiss RB, Creekmore SP, Micetich KC, Curt GA (1986) Carboplatin for advanced colorectal carcinoma: a phase II study. Cancer Treat Rep 70: 301 – 302
Pettigrew RT, Gait JM, Ludgate CM, Horn DB, Smith AN (1974) Circulatory and biochemical effects of whole body hyperthermia. Br J Surg 61: 727 – 730
Pettigrew RT, Gait JM, Ludgate CM, Smith AN (1974b) Clinical effects of whole body hyperthermia in advanced malignancy,. BMJ 4: 679 – 682
Posner M, Lienard D, Lejeune F, Rosenfelder D, Kirkwood J (1994) Hyperthermic isolated limb perfusion (HILP) with tumor necrosis factor (TNF) alone for metastatic intransit melanoma. Proc ASCO 13: 396, 1351
Robins HI (1991) Combined modality clinical trials for favorable B-cell neoplasms: lonidamine plus whole body hyperthermia and/or total body irradiation. Semin Oncol 18: 23 – 27
Robins HI, Neville AJ (1986) Biology and methodology of whole-body hyperthermia. In: Angileri, Robert (eds) Hyperthermia in cancer treatment. CRC Press, Boca Raton, FL, pp 183 – 206
Robins HI, Dennis W, Martin P, Sondel P, Yatvin M, Steeves R (1984) Potentiation of differential hyperthermic sensitivity of AKR leukemia and normal bone marrow cells by lidocaine or thiopental. Cancer 54: 2831 – 2835
Robins HI, Dennis WH, Neville AJ, et al. (1985) A nontoxic system for 41.8°C whole body hyperthermia: results of a phase I study using a radiant heat device. Cancer Res 45: 3937 – 3944
Robins HI, Longo WL, Steeves R, et al. (1988) A pilot study of whole body Hyperthermia and local irradiation for aduanced non-small cell lung cancer confined to the thorax. The International Journal of Radiation Oncology Biology & Physics 15: 427 – 431
Robins HI, Sielaff KM, Storer B, Hawkins MJ, Bofden EC (1989) Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer. Cancer Res 49: 1609 – 1615
Robins HI, Longo W, Steeves R, et al. (1990) Adjunctive therapy (whole body hyperthermia) versus lonidamine to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations. Int J Radiat Oncol Biol Phys 18: 909 – 920
Robins HI, Cohen JD, Schmitt CL, et al. (1993) Phase I clinical trial of carboplatin and 41.8°C whole body hyperthermia. J Clin Oncol 11: 1787 – 1794
Rohner R, Peior J, Sipple J (1966) Mucinous malignancies, venous thrombosis and terminal endocarditis with emboli: a syndrome. Cancer 19: 1805 – 1810
Roizin-Towle L, Hall E (1982) Interaction between hyperthermia and cytotoxic agents,. NCI Monogr 61: 149 – 151
Rose WC, Veras G, Laster WRJ, Schabel FMJ (1979) Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumors,. Cancer Treat Rep 63: 1311 – 1325
Sack G, Levin J, Bell W (1977) Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms; clinical, pathologic and therapeutic features. Medicine
Sakaguchi Y, Stephens L, Danhauser L, Makino M, Strebel FR, Jenkins G, Bull JMC (1993) Enhancement of antitumor effect and induction of apoptosis by a combination of 5-fluorouracil and whole body hyperthermia in rats. Proc Am Assoc Cancer Res 34: 361 (2151)
Sakaguchi Y, Stephens L, Kaneko T, Danhauser L, Strebel FR, Jenkins G, Bull JMC (1994a) Apoptosis and tumor response induced by 5-fluorouracil and whole body hyperthermia in rats. Proc 85th meeting of Am Assoc Cancer Res 35: 151 (3352)
Sakaguchi Y, Stephens LC, Makino M, Danhauser LL, Strebel FR, Jenkins GN, Kaneko T, Bull JMC (1993b) Efficacy of prolonged intravenous infusion of 5-fluorouracil combined with hyperthermia in vivo: apoptosis and tumor response. Proc Amer Assoc Cancer Res 34: 361 (2151)
Sakaguchi Y, Stephens LC, Makino M, Kaneko T, Strebel FR, Danhauser LL, Jenkins GN (1994c) Apoptosis and tumor response induced by 5-fluorouracil and whole body hyperthermia in vivo. Proc Amer Assoc Cancer Res 36: 151 (3352)
Sakaguchi Y, Makino M, Kaneko T, et al. (1994d) Therapeutic efficacy of long-duration-low-temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cancer Res 54: 2223-2227
Seegenschmiedt MH, Martus P, Fietkau R, Iro H, Brady L, Sauer R (1994) Multivariate analysis of prognostic parameters using interstitial thermoradiotherapy (IHT- IRT): tumor and treatment variables predict outcome. Int J Radiat Oncol Biol Phys 29: 1049 – 1063
Selker RG, Jacobs S, Stoller R, Kristojik M, Randall M (1983) On the limits of human tolerance to whole body hyperthermia and simultaneous chemotherapy. Radiat Res 94: 550 – 555
Shen R, Hornback N, Shidnia H, Wu B, Lu L, Broxmeyer H (1991) Whole body hyperthermia: a potent radio- protector in vivo. Int J Radiat Oncol Biol Phys 20: 525 – 530
Shen R, Lu L, Young P, Shidnia H, Hornback N, Broxmeyer H (1994) Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells. Int J Radiat Oncol Biol Phys 29: 821 – 826
Song CW, Lin J-C, Lyons JC (1993) Antitumor effect of interleukinla in combination with hyperthermia. Cancer Res 53: 324 – 328
Spero J, Lewis J, Hasiba U (1980) Disseminated intravascular coagulation: findings in 346 patients. Thromb Haemost 43: 28 – 34
Srinivasan J, Fajardo L, Hahn G (1990) Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in a tumor necrosis factor alpha-resistant tumor. J Natl Cancer Inst 82: 1904 – 1910
Stark P, Guthrie A, Bull J (1985) Thoracic radiographic changes after systemic hyperthermia for advanced cancer. Radiology 154: 55 – 58
Steeves RA, Robins HI, Miller K, Martin P, Schecterk L, Dennis W (1987) Interaction of whole-body hyperthermia and irradiation in the treatment of AKR mouse leukemia,. Int J Radiat Biol 52: 935–947 Stehlin JJ, Giovanella B, de Ipolyi P, Muenz L, Anderson R (1975) Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 140: 339 – 348
Stehlin JJ, Giovanella B, de Ipolyi P, Anderson R (1979) Results of eleven years1 experience with heated perfusion for melanoma of the extremities. Cancer Res 39: 2255 – 2257
Strebel FR, Ohno S, Stephens LC, Siddik ZH, Travis EL, Khokhar AR, Bull JMC (1991) Comparison of the acute and chronic normal tissue toxicities of cisplatin and carboplatin combined with WBH in rats. Dewey WC, Edington N, Fry RJM, Hall EJ, Whitmore GF (eds) The 9th international congress of radiation research 1991. Academic Press Inc., Sandigo
Strother S, Branham S, Bull JMC (1986) Activation of coagulation during therapeutic whole body hyperthermia. Thromb Res 43: 353 – 360
Suzuki K (1967) Application of heat to cancer chemotherapy - experimental studies. Nagoya J Med Sci 30: 1 – 21
Takahashi H, Tanaka R, Sekihara Y, Hondo H (1991) Auditory brainstem response during systemic hyperthermia. Int J Hyperthermia 7: 613 – 620
Tapazoglou E, Robins H, Cohen J, Khatana A, Schmitt C, Franken K, Sapareto SA (1990) The enhancement of cytotoxicity of carboplatin (CBDCA) by whole body hyperthermia (WBH) in murine AKR leukemia. 38th Ann Meeting of the Rad Res Soc 10th Ann Meeting of the North American Hyperthermia a Group 1990 26 (AN-5)
Teicher B, TSH, Menon K, Korbut T (1992) Whole-body hyperthermia as an adjuvant to treatment with platinum complexes with and without etanidazole in mice bearing the Lewis lung carcinoma or the FSaLL fibrosarcoma. Int J Hyperthermia 8: 783 – 794
Thrall DE, Page RL, Dewhirst MW, Meyer RE, Hoopes PJ, Kornegay JN (1986) Temperature measurements in normal and tumor tissue of dogs undergoing whole body hyperthermia. Cancer Res 46: 6229 – 6235
Thrall DE, Dewhirst MW, Page RL, Samulski TV, McLeod DA, Oleson JR (1990) A comparison of temperatures in canine solid tumours during local and whole-body hyperthermia administered alone and simultaneously. Int J Hyperthermia 6: 305 – 317
Tonnesen A, Marnock C, Bull JMC, Morgenweck C, Fallon K (1987) Sweating, hemodynamic responses, and thermal equilibration during hyperthermia in humans. J Appl Physiol 62: 1596 – 1602
Tsumura M, Yoshiga K, Takada K (1988) Endancement of antitumour effects of l-helycarbamyl-5-fluorouracil combined with hyperthermia on Ehrlich ascites tumor in vivo and Nakahara-Fukuoka sarcoma cell in vitro. Cancer Res 48: 3977 – 3980
Twentyman P, Morgan J, Donaldson J (1978) Enhancement by hyperthermia of the effect of BCNU against the EMT6 mouse tumor. Cancer Treat Rep 62: 439 – 443
Urano M, Kahn J, Kenton LA (1988) Effect of bleomycin on murine tumour cells at elevated temperatures and two different pH values,. Cancer Res 48: 615 – 619
Valdagni R, Amichetti M (1994) Report of long- term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28: 163 – 169
van der Zee J, Van Rhoon GC, Wilce-Hooley JL, Faith- full NS, SRH (1983) Whole-body hyperthermia in cancer therapy: a report of a phase I–II study. Eur J Cancer 19: 1189–1200
Van der Zee J, Faithfull NS, van Rhoon GC, Reinhold HS (1987) Whole body hyperthermia as a treatment modality. Nato Asi Ser E 127: 420 – 440
Wallner KE, DeGregario MW, Li GC (1986) Hyperthermic potentiation of cis-diamminedichloroplatinum (II) cytotoxicity in Chinese hamster ovary cells resistant to the drug,. Cancer Res 46: 6242 – 6245
Wang B, Lumanglas A, Silva J, Ruszala-Mallon V, Durr F (1987) Effect of hyperthermia on the sensitivity of human colon carcinoma cells to mitoxantrone,. Cancer Treat Rep 61: 831 - 836
Warren SL (1935) Preliminary study of the effect of artificial fever on hopeless tumor cases,. Am J Roentgenol 33: 75 – 87
West K, Weber T, Grosfeld J (1980) Snergistic effect of hyperthermia, papaverine, and chemotherapy in murine neuroblastoma,. J Pediatr Surg 15: 913 – 917
Wondergem J, Bulger R, Strebel FR, Newman R, Travis E, Stephens L, Bull JMC (1988a) Effect of cis- diamminedichloroplatinum (II) combined with whole body hyperthermia on renal injury. Cancer Res 48: 440 – 446
Wondergem J, Strebel FR, Siddik ZH, Newman R, Bull JMC (1988b) The effects of anesthetics on cisplatinum- induced toxicity at normal temperatures and during whole body hyperthermia: the influence of NaCl concentration of the vehicle. Int J Hyperthermia 4: 643 – 654
Wondergem J, Stephens LC, Strebel FR, et al. (1991) Effect of adriamycin combined with whole body hyperthermia on tumor and normal tissues. Cancer Res 51: 3559 – 3567
Wondergem J, Siddik ZH, Strebel FR, Bull JMC (1993) Effect of whole body hyperthermia on cis-diamminedichloroplatinum (Il)-induced antitumor activity and tissue Pt-distribution: do anesthetics influence the therapeutic ratio? Eur J Cancer 29A: 549 – 554
Wondergem J, Strebel FR, Stephens LC, Siddik ZH, Bull JMC (1995) Chronic effect of whole body hyperthermia combined simultaneously with cis-diamminedichloro-platinum II on normal tissue in rats. Int J Hyperthermia 11: 37 – 49
Yamane T, Nakabayashi H, Ito S, Sumii H, Kawal A (1986) In vitro thermochemotherapy of human osteosarcoma cells with cis-dichlorodiammineplatinum (II). Hiroshima J Med Sci 35: 191 – 195
Yatvin M (1977) The influence of membrane liquid composition and procaine on hyperthermic death of cells. Int J Radiat Biol 32: 513 – 521
Yatvin M, Clifton K, Dennis W (1979) Hyperthermia and local anesthetics: potentiation of survival in tumor- bearing mice. Science 205: 195 – 196
Yerushalmi A (1978) Combined treatment of a solid tumour by local hyperthermia and actinomycin D. Br J Cancer 37: 327 – 832
Yerushalmi A, Hazan G (1979) Control of Lewis lung carcinoma by combined treatment with local hyperthermia anc cyclophosphamide: preliminary results. Isr J Med Sci 15: 462 – 463
Yerushalmi A, Tovey G, Gresser I (1982) Antitumor effect of combined interferon and hyperthermia in mice. Proc Soc Exp Biol Med 169: 412 – 415.
Zupi G, Badaracco G, Caraliere R, Natali PG, Greco C (1987) Influence of sequence on hyperthermia and drug Combination in Hyperthermic Oncology, Over-quards (ed) Taylor and Francis Press, London vol 1: 429 – 432
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bull, J.M.C. (1996). Clinical Practice of Whole-Body Hyperthermia: New Directions. In: Thermoradiotherapy and Thermochemotherapy. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60938-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-60938-1_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64613-3
Online ISBN: 978-3-642-60938-1
eBook Packages: Springer Book Archive